Markets

Fresenius Medical Care Appoints Shervin J. Korangy As CEO Effective October 12; Shervin J. Korangy To Succeed Helen Giza

Oct 7, 2026 · 11:32 AM ET· updated 1h ago

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced that Shervin J. Korangy (51) will become Chief Executive Officer (CEO) and

Why It Matters

Fresenius Medical Care has a new leader starting in October. When a company gets a new CEO, watch how the business runs going forward.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

FMS20.83

-1.59 (-7.09%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.